Innate Immune Signaling Mechanisms in Inflammation

The innate immune system relies on germ-line encoded receptors to detect pathogens and tissue damage and to initiate inflammation. Pattern recognition receptors such as Toll-like receptors (TLRs) and nucleotide-binding oligomerisation domain (NOD)-like receptors engage conserved microbial structures, triggering intracellular signalling cascades. These cascades include activation of mitogen-activated protein kinases (MAPKs) and the transcription factor NF-κB, as well as assembly of inflammasome complexes, which together orchestrate cytokine release, cell recruitment and pathogen clearance. Counter-regulatory mechanisms, including phosphatases and ubiquitin-mediated degradation of signalling intermediates, ensure that responses are transient and prevent excessive tissue injury. Crosstalk among pathways such as the PI3K/Akt axis further shapes the amplitude and duration of inflammation. Dysregulation of these signalling networks underlies sepsis, chronic inflammatory diseases and autoimmunity. Understanding these mechanisms has fostered the development of targeted anti-inflammatory therapies and host-directed immunomodulation, with broad implications for global health and precision medicine.

Research from Nature Portfolio

Recent studies have illuminated novel regulators of innate signalling. One foundational study revealed that p38 MAPK-mediated phosphorylation of microtubule-associated protein 4 at specific serine residues leads to microtubule disassembly and endothelial barrier disruption in models of acute lung injury. Pharmacological inhibition of p38 or stabilisation of microtubules restored junctional integrity, highlighting a direct link between inflammatory kinase activation and vascular permeability. In a complementary mechanism, the transmembrane adaptor SCIMP was identified as a non-TIR-containing partner of TLR4 in macrophages. SCIMP associates constitutively with Lyn kinase and, upon lipopolysaccharide stimulation, facilitates tyrosine phosphorylation of TLR4, selectively augmenting production of key proinflammatory cytokines such as interleukin-6 and interleukin-12p40. These findings reveal immune-restricted adaptors that shape the specificity and magnitude of TLR-driven inflammation.

Innate Immune Signaling Mechanisms in Inflammation publication trend

The graph below shows the total number of articles in innate immune signaling mechanisms in inflammation across all publications each year (not limited to Nature Index journals).

Technical terms

Toll-like receptors (TLRs): Membrane-bound pattern recognition receptors that detect pathogen-associated molecular patterns and initiate innate immune signalling.

Adaptor protein: A non-enzymatic molecule that links activated receptors to downstream signalling modules, determining specificity and magnitude of responses.

Mitogen-activated protein kinase (MAPK): A family of serine/threonine kinases that transmit extracellular stress or cytokine signals to regulate gene expression and cellular responses.

E3 ubiquitin ligase: An enzyme that catalyses the attachment of ubiquitin to target proteins, marking them for proteasomal degradation or altering their activity.

PI3K/Akt pathway: A kinase cascade initiated by phosphoinositide 3-kinase that activates Akt, controlling cell survival, metabolism and modulation of inflammatory signalling.

References

1. The E3 Ubiquitin Protein Ligase LINCR Amplifies the TLR-Mediated Signals through Direct Degradation of MKP1. Cells (2024).
2. Sulfate-Reducing Bacteria Induce Pro-Inflammatory TNF-α and iNOS via PI3K/Akt Pathway in a TLR 2-Dependent Manner. Microorganisms (2024).
3. P38/MAPK contributes to endothelial barrier dysfunction via MAP4 phosphorylation-dependent microtubule disassembly in inflammation-induced acute lung injury. Scientific Reports (2015).
4. SCIMP is a transmembrane non-TIR TLR adaptor that promotes proinflammatory cytokine production from macrophages. Nature Communications (2017).
5. Innate recognition of microbial-derived signals in immunity and inflammation. Science China Life Sciences (2016).